SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: 993racer who wrote (104)9/30/1997 11:44:00 PM
From: Diane Leadman   of 369
 
I just got this off Individual Investor online.

"UroMed is starting to gain momentum. The market seems to have written off the problems with the Reliance product and are now focusing on the 1998 launch of the Impress soft patch. The stock is also reacting well to a new product unveiling that will take place in New York City for the investment community on October 21. The company plans to introduce and demonstrate new male and female product lines to be launched in the next 12 to 18 months." We reiterate our Buy rating with a price target of $8 per share. (Posted on 9/25/97 with URMD at $5.63.)

It would be nice to see it go to $8 since that's what I paid for it!

Diane
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext